BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han RS, Hao JW, Wang T, Xin Z, Fan GX, Wang GD, Liu MM, Liu CX, Yang QZ, Yang ZW, Lv XY, Zhang C, Bian G, Meng J, Cui ZQ, Yun XJ, Cao JH, Li SH, Fan JF, Ma HG, Gao FY, Mao T, Tian ZB, Song XH, Yu YN. Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial. World J Gastroenterol 2025; 31(28): 109001 [PMID: 40741473 DOI: 10.3748/wjg.v31.i28.109001]
URL: https://www.wjgnet.com/2222-0682/full/v31/i28/109001.htm
Number Citing Articles
1
Yinhua Liao, Hu Liu, Yibin Zhou, Zhenyu Wang. Efficacy and safety of antibiotic regimens for Helicobacter pylori eradication: a systematic review and meta-analysisFrontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1780052
2
Ming-Xian Chen, Chu-Ying Sun. Additional considerations on vonoprazan triple therapy for <i>Helicobacter pylori</i> eradication: Implementation challenges and clinical perspectivesWorld Journal of Gastroenterology 2025; 31(46): 113528 doi: 10.3748/wjg.v31.i46.113528
3
Tareq Alsaleh, Celise Nardes Ferreira, Hamza Akram, Calvin Jose, Mohamad Khaled Almujarkesh, John George. Ten vs. 14 Days of Vonoprazan‐Based Therapy for Helicobacter pylori: Systematic Review and Meta‐Analysis of Randomized TrialsJournal of Gastroenterology and Hepatology 2026;  doi: 10.1111/jgh.70367
4
O. Dudanova. Diagnosis and Treatment of Chronic Helicobacter pylori-Associated Gastritis: Achievements and What Hinders Further Success?Meditsinskaya sestra 2026; : 26 doi: 10.29296/25879979-2026-02-04
5
Alexei Goncharov, Vasily Isakov. Breaking barriers in the first-line <i>Helicobacter pylori</i> treatment: Chinese multicenter trial validates vonoprazan-based triple therapyWorld Journal of Gastroenterology 2025; 31(40): 112312 doi: 10.3748/wjg.v31.i40.112312
6
Yurong Huang, Juan Zheng, Zhengyi Yang, Daili Li, Hua Wu, Wenzhong Chen, Wenjuan Wang, Min Gan, Changmei Shi, Dongmei Xie, Canyu Zhan, Gengqing Song, Jie Yang. Real-world effectiveness of vonoprazan-based regimen versus rabeprazole-based dual therapy for Helicobacter pylori eradication in a high-resistance, multi-ethnic region: a multicenter study in Guizhou, ChinaFrontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1801129